A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation
type: MedicalStudy
description: A Phase III Prospective, Randomized, Double-Blind, Active-Controlled, Multi-Center, Superiority Study of Vernakalant Injection Versus Amiodarone in Subjects With Recent Onset Atrial Fibrillation
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2008-04
end date: 2009-11
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00668759
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Advanz Pharma
study subject: Atrial Fibrillation
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Atrial Fibrillation

AI Analytics
type: Organization